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Numerous hypotheses have been proposed about the pathogenesis of the polycystic ovarian syndrome (PCOS). 
However, hormonal control of persistent follicles has not been established. The objective of the present study was to 
compare the follicular structure and hormonal profiles of rats treated with the adrenocorticotrophic hormone (ACTH) 
with two experimental models of PCOS. ACTH-treated animals were compared with those exposed to continuous light, 
those treated with estradiol valerate, and with control (in proestrous and diestrous). Serum hormone levels, 
histomorphometrical changes, and immunoexpression of vimentin, cytokeratins, cadherins, and proliferating cell 
nuclear antigen (PCNA) were examined. Treatment with ACTH resulted in an elevation of corticosterone secretion with 
LH reduction but without changes in ovarian morphology. Although stress (or ACTH) stimulation may be only one of 
pathophysiological mechanisms involved in follicular cyst pathogenesis in other species, we do not have important 









 Polycystic ovarian syndrome (PCOS) is the most 
common and least understood endocrine disorder 
affecting approximately 5 % of women of reproductive 
age. It is considered a syndrome not a disease, although 
the term “polycystic ovarian disease” is often used 
synonymously, but incorrectly, to describe this syndrome, 
which is manifested by heterogeneous clinical symptoms 
(Xita et al. 2002). 
 Numerous experimental models to assess PCOS 
in rats have been developed. The following hormonal 
substances, among others, have been employed to induce 
this condition: estradiol valerate, dehydroepi-
androsterone, neonatal androgenization, and continuous 
light exposure (Mahesh et al. 1987, Mahajan 1988, 
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Salvetti et al. 2003, 2004a,b). 
 On the other hand, stress has been implicated in 
the etiology of spontaneously occurring persistent 
follicles in cattle and sheep. In cattle, the preovulatory 
luteinizing hormone (LH) surge is sensitive to the 
inhibitory effects of exogenous adrenocorticotrophic 
hormone (ACTH), and such inhibition results in the 
development of persistent follicles (Phogat et al. 1997, 
Dobson et al. 2000). However, the reproductive hormonal 
control of the consequent development of either the 
persistent follicle or subsequent follicles was not 
examined in these studies. 
 The objective of the present study was to 
compare the follicular structure and hormonal profiles of 





Animals and treatment 
 Female Wistar rats (175–200 g) were provided 
by the Center for Experimental Biology and Laboratory 
Animal Sciences, Faculty of Veterinary Sciences, UNL. 
Before the experiment, the animals were kept under 
controlled cycle of light and darkness (lights on from 
06:00 to 20:00 h), and a temperature range of 20-24 ºC 
with free access to water and commercial food (Cargill, 
Argentina). Lighting was provided by banks of General 
Electric 4 coolwhite 40-W fluorescent tubes to obtain a 
light intensity of 350 lux at 1 m above the floor (Salvetti 
et al. 2004a). All procedures were carried out according 
to the Guide for the Care and Use of Laboratory Animals 
(National Research Council 1996). 
 Forty animals displaying at least two normal 4-5 
days of estrous cycles, just before treatment, were 
allocated to four groups: The control group received an 
equivalent volume of vehicle and the animals were 
sacrificed after 10 weeks, in proestrous (C-P) (n = 5) to 
obtain serum and preovulatory tertiary follicles, and in 
diestrous (C-D) (n = 5) to obtain serum and growing 
follicles. The animals in the continuous light group (L) 
were placed in the conditions described, except that the 
light was extended to 24 h and the rats were sacrificed 
after 105 days (Salvetti et al. 2004a). The estradiol 
valerate (EV)-treated group was injected with a single 
2-mg IM dose of EV and the rats were sacrificed at 
60 days (Progynon Depot, Schering, Buenos Aires, 
Argentina) (Schulster et al. 1984, Farookhi et al. 1985). 
The animals belonging to the ACTH-treated group 
received an equivalent to 20 UI/kg (200 μg/kg) of ACTH 
(ACTHElea, Elea, Buenos Aires, Argentina) 
subcutaneously every 24 h for 18 days and were 
sacrificed 24 h after the last injection (Fraser et al. 2001, 
Kitamura et al. 2002). 
 
Vaginal smears 
 Smears obtained by vaginal washing were 
examined under a microscope for the relative abundance 
of nucleated epithelial cells, cornified cells, and 
leukocytes. Cycles with duration of 4–5 days were 
considered regular. The observation of cornified cells in 
the smears during a minimum of 10 serial days was 
defined as persistent vaginal cornification (PVC) and 
considered to be an indication of follicular cystic 
development (Salvetti et al. 2004a). 
 
Tissue sampling 
 All the animals were killed by decapitation, at 
around 9:00 h, trunk blood was collected, and the serum 
stored at –20 ºC until used for hormone assays. The 
ovaries were dissected and fixed in 10 % buffered 
formalin for 6 h at room temperature and washed in a 
phosphate buffer saline (PBS) solution. For light 
microscopy, fixed tissues were dehydrated in an 
ascending series of ethanol, cleared in xylene, and 
embedded in paraffin. Five-micrometer thick sections 
were mounted in slides previously treated with  
3-aminopropyltriethoxysilane (Sigma-Aldrich, St. Louis, 




 Details and concentration of the antibodies used 
are summarized in Table 1. Each antibody was assayed in 
at least five sections of each ovary from each individual. 
The streptavidin-biotin immunoperoxidase method was 
done as previously described (Ortega et al. 2004, Salvetti 
et al. 2004b). In brief, sections were deparaffinized and 
hydrated, and given microwave pretreatment (antigen 
retrieval). The endogen peroxidase activity was inhibited 
with 1 % H2O2 and nonspecific binding was blocked with 
10 % normal goat serum. All sections were incubated 
with the primary antibodies for 18 h at 4 ºC and then for 
30 min at room temperature with rat-preabsorbed 
biotinylated secondary antibodies selected specifically to 
each of the two types of primary antibodies used 
(monoclonal or polyclonal). The visualization of antigens 
was achieved by the streptavidin–peroxidase method 
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Table 1. Used antibodies, suppliers and dilutions. 
 
Antibodies Clone Supplier Dilution 
Primary antibodies    
 Vimentin (VIM) V9 Zymed Prediluted 
 Cytokeratins (1/5/6/8/10/14/18) (CKs) LP 34, 34βE12 & 35βH11 Dako Prediluted 
 pan-Cadherin (GFAP) Polyclonal Zymed 1:50 
 Proliferation cellular nuclear antigen (PCNA) PC10 Novocastra 1:200 
Secondary antibodies    
 Anti-rabbit IgG Polyclonal Zymed 1:300 
 Anti-mouse IgG Polyclonal Chemicon 1:120 
 
 
 (BioGenex, San Ramon, CA) and 3.3-diaminobenzidine 
(Liquid DAB-Plus Substrate Kit – Zymed, San Francisco, 
CA) was used as chromogen. Finally, the slides were 
washed in distilled water and counterstained with 
Mayer’s hematoxylin, dehydrated, and mounted. To 
verify specificity, adjacent control sections were 
subjected to the same immunohistochemical method, 




 Image analysis was performed using Image Pro-
Plus 3.0.1® system (Media Cybernetics, Silver Spring, 
MA, USA). Images were digitized by a CCD color video 
camera (Sony, Montvale, NJ, USA) mounted on top of a 
conventional light microscope (Olympus BH-2, Olympus 
Co., Japan) using ×4, ×10, and ×40 objective lenses. 
Microscopic fields covering the entire follicular wall area 
were digitized and stored in a 24-bit true color TIFF 
format. 
 Follicular mean diameter and the granulosa and 
theca thickness were analyzed using specific tools of the 
software. The immunohistochemical stained area 
(IHCSA) was calculated as a percentage of total area, 
assessed by color segmentation analysis, which produces 
quantification by locating all objects of a specific color 
(brown stain). The images were then transformed to a 
bilevel scale TIFF format (Salvetti et al. 2004b). The 
IHCSA (black area) was calculated from at least 25 
images of each area (granulosa, theca externa, and theca 
interna) in each slide. 
 
Hormone assays 
 Follicle-stimulating hormone (FSH) and LH 
serum levels were determined by radioimmunoassay 
(RIA) using the kit provided by NIDDK (USA) as 
previously described (Ortega et al. 2004). Intra- and 
inter-assay coefficients of variation for LH and FSH were 
less than 8 % and 12 %, respectively. Minimum 
detectable concentrations were 0.16 and 1.18 ng ml–1 of 
serum for LH and FSH, respectively. 
 Serum estradiol and progesterone were estimated 
by RIA using highly specific antiserum provided by Dr. 
G.D. Niswender (NIDDK) (Korenman et al. 1974). 
Labeled hormones were purchased from Amersham 
(UK). Assay sensitivity for estradiol was 1.7 pg and intra- 
and interassay coefficients of variation were 9.3 % and 
11.4 %, respectively. Assay sensitivity for progesterone 
was 50 pg and intra- and inter-assay coefficients of 
variation were 7.5 % and 11.9 %, respectively (Chamson-
Reig et al. 1999). 
 After ethyl-ether extraction, the serum 
testosterone was determined by RIA using a specific 
antiserum provided by Dr. G.D. Niswender (NIDDK). 
Labeled hormone was purchased from New England 
Nuclear (Boston, MA, USA). Assay sensitivity: the 
lowest point in the testosterone standard curve was 
12.5 pg and the lowest detectable concentration when 
extracting 150 μl serum was 208.3 pg/ml. Intra- and inter-
assay coefficients of variation were 7.8 % and 12.3 %, 
respectively (Bianchi et al. 2004). 
 Corticosterone concentration was determined by 
extracting 25 μl of serum sample with 1 ml of 
dichlormethane (Merck, Westpoint, PA, USA). The 
solvent was decanted and dried at 50 ºC. Fifty microliters 
of 1-alpha-2-alpha-N(3H) corticosterone (Amersham, 
UK; 10000 cpm approximately) were diluted with 200 μl 
of standard solutions or unknown samples and 50 μl of 
anticorticosterone rabbit serum. The tubes were incubated 
overnight at 4 ºC and the separation of bound and free 
hormone fractions was achieved by the addition of 100 μl 
of charcoal (1 g %)-dextran (0.1 g %) suspension. Bound
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Table 2. Histomorphometric analysis of follicular wall of ovaries in control and treated rats*. 
 
 C-P L EV ACTH 
Follicle mean diameter 526.45 ± 32.53 a 765.37 ± 29.56 b 684.79 ± 48.98 b 561.31 ± 25.33 a 
Granulosa thickness 55.42 ± 5.24 a 62.46 ± 10.09 a 33.04 ± 4.17 b 63.00 ± 2.50 a 
Theca interna thickness 14.17 ± 1.24 a 16.04 ± 1.66 a 9.94 ± 0.74 b 16.08 ± 1.70 a 
Theca extrena thickness 11.80 ± 1.01 10.65 ± 1.38 11.57 ± 1.34 8.79 ± 0.86 
 
* Values represent mean ± SEM (μm). Different letters within a row indicate significant differences (p<0.05) 
 
 
Table 3. Distribution of immunoreactivity in the follicular wall of ovaries in controls and treated rats. 
 
 C-P L EV ACTH 
Vimentin     
 Granulosa 7.76 ± 0.46 a 30.62 ± 2.48 b 23.70 ± 3.23 c 8.90 ± 2.01 a 
 Theca interna 5.98 ± 0.64 5.62 ± 0.76 7.32 ± 2.47 4.40± 1.13 
 Theca externa 2.29 ± 0.28 a 2.31 ± 0.45 a 6.32 ± 1.66 b 2.94 ± 0.89 a 
Cytokeratins     
 Granulosa 0.94 ± 0.20 a 19.96 ± 1.48 b 15.28 ± 2.00 c  1.19 ± 0.44 a 
 Theca interna - - - - 
 Theca externa - - - - 
Pan-Cadherin     
 Granulosa 11.02 ± 1.44 a  26.74 ± 2.04 b 31.14 ± 4.13 b 9.76 ± 3.06 a 
 Theca interna 5.88 ± 0.47 a 16.96 ± 2.27 b 14.38 ± 1.44 b 6.61 ± 2.37 a 
 Theca externa 0.43 ± 0.28 0.65 ± 0.17 0.60 ± 0.19 0.53 ± 0.17 
PCNA     
 Granulosa 8.29 ± 0.76 a 2.34 ± 0.54 b 1.72 ± 0.26 b 6.89 ± 0.96 a 
 Theca interna 9.49 ± 0.76 a 2.08 ± 0.62 b 0.76 ± 0.17 b 8.15 ± 0.99 a 
 Theca externa 3.53 ± 0.64 a 1.01 ± 0.31 b 0.38 ± 0.13 b 3.30 ± 0.54 a 
 




radioactivity was determined in an LKB β-counter. The 
intra- and inter-assay coefficients of variation ranged 




 A statistical software package (SPSS 11.0 for 
Windows, SPSS Inc., Chicago, IL, USA) was used for 
performing the statistical tests. The statistical significance 
of differences was assessed by one-way ANOVA, 
followed by Duncan’s multiple range test as a multiple 
comparison test. P<0.05 values were considered 




 The animals in the control group showed normal 
cycles during the whole experiment. In the constant light-
exposed group, all animals showed irregular cycles 
within 3 weeks and PVC within 13 weeks of permanent 
light exposure. In the EV-treated group, all animals 
displayed irregular cycles within 1 week of EV treatment 
and most (90 %) showed PVC by 3 weeks after injection. 
In the ACTH group, all animals showed irregular cycles 
during the whole experience. 
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Fig. 1. Sections of ovaries from control (proestrous) (a,e,g,i,k), constant light-exposed (b,f,h), estradiol valerate-treated (c,j,l) and 
ACTH treated (d) rats staining with hematoxylin-eosin (a,b,c,d) and immunostaining with vimentin (e,f), cytokeratins (g,h) and PCNA 




 Ovaries from the control group exhibited 
follicles in various stages of development. Preovulatory 
tertiary follicles and growing secondary follicles were 
observed in proestrous, whereas only secondary follicles 
and fresh corpora lutea were seen in diestrous. 
Primordial, primary, and atretic follicles, as well as 
interstitial glands, were found in both control groups. In 
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constant light-exposed animals, small follicles in early 
development were observed, in addition to follicles 
showing evidence of atresia, and many large cysts with 
thickened granulosa cell layer or large cystic follicles 
with scant granulosa cells. Corpus luteum was absent and 
hyperplasia of interstitial glands was observed. The 
ovaries of EV-treated animals showed follicular cysts, 
although primary and early secondary follicles were 
present. There was a conspicuous absence of both large 
secondary and tertiary follicles as well as corpus luteum. 
In ACTH-treated animals, the ovarian morphology was 
similar to the control animals. 
 
Histomorphometry 
 Histomorphometric results are listed in Table 2. 
The average diameter of cystic follicles was significantly 
higher in constant light-exposed and EV-treated rats. The 
thickness of granulosa, theca interna, and theca externa 
did not show significant differences among C-P, C-D, L, 
or ACTH groups. In the EV-treated rats, a significant 
reduction in the thickness of the granulosa and theca 
interna was evident. 
 
Immunohistochemistry 
 A summary of the immunohistochemical 
(IHCSA) expression for the different antibodies is given 
in Table 3 and Figure 1. The granulosa cell layer of cystic 
follicles in the L and EV groups had a significantly 
greater IHCSA for vimentin than the C-P and ACTH 
antral follicles. The theca interna cells in C-P ovaries, 
similarly as in the treated ovaries, showed a moderate 
positive immunostaining without differences in the 
IHCSA. Some theca externa cells showed weak staining 
in all follicles studied, and a higher IHCSA was observed 
in EV-treated rats. 
 Cytokeratins (CKs) showed a low expression in 
the granulosa cells of antral follicles in the C-P and 
ACTH-treated animals, whereas in granulosa cells of 
cystic follicles, L and EV groups showed significantly 
higher IHCSA. No immunostaining was detected in theca 
cells. 
Immunostaining for p-cadherins was observed in 
the granulosa and theca interna of cystic follicles (L and 
EV groups) and weak and irregular immunostaining was 
seen in the theca externa. 
Cellular proliferation, evaluated through the 
expression of proliferating cell nuclear antigen (PCNA), 
showed a high index in the whole follicular wall in antral 
follicles of C-P and ACTH. This was significantly 
decreased in L and EV groups. 
 
Hormone levels 
 Hormone serum levels are shown in Figure 2. 
The three treatments induced a significant reduction in 
LH and FSH levels as compared to C-P animals. 
Estradiol serum levels in EV-treated and L animals 
showed significant increments, while in ACTH-treated 
animals, the levels were similar to those of proestrous 
animals. The levels of progesterone in the treated animals 
were similar to those of proestrous animals. Testosterone 
serum concentrations varied with a significant reduction 
in L and EV animals in relation to C-D. Corticosterone 
showed an increase in the ACTH group and a significant 




 Why and how ovaries become polycystic have 
been the subject of considerable speculation as well as the 
object of meticulous studies with different approaches 
(Barberi 1991, Agarwal and Shankar 1998, Hoo and 
Shaw, 2005, Raja et al. 2005). Nevertheless, little is 
known about the mechanisms that cause their 
development. The etiology and pathogenesis of follicular 
cysts have been the subject of numerous hypotheses since 
the middle of the 19th century. However, to this day, they 
are still not completely clarified either in humans or in 
animals (Barberi 1991, Hamilton et al. 1995, Garverick 
1997, Silvia et al. 2002, Peter 2004). 
 In this work, both L and EV groups develop 
polycystic ovaries. The hormonal levels; vimentin, CKs, 
and cadherins immunoexpression; and follicular wall 
morphometry differed markedly from those of the control 
group, indicating that polycystic ovaries do not define a 
single disorder, but rather a general class of conditions 
encompassing a variety of individual expressions.  
 In this sense, the PCOS has been considered a 
progressive multiglandular endocrinopathy where the 
delicate balance of the hypothalamic–pituitary–adrenal–
ovarian axis is disturbed, resulting in a failure of the 
cyclic reproductive mechanism (Mahesh et al. 1987, 
Hamilton et al. 1995). A total loss of the cyclic 
reproductive changes appears to follow a phase of 
irregular rhythmicity in rats experimental PCOS (Salvetti 
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Fig. 2. Medial values, interquartile intervals (box) and range (whiskers) for LH, FSH, estradiol (E), progesterone (P), testosterone (T) 
and corticosterone (Ct) in control-proestrous (C-P), control-diestrous (C-D), constant light-exposed (L), estradiol valerate-treated (EV) 




 Ovarian morphology provides both a convenient 
and appropriate measurement to describe cystic status as 
differences were found in the morphometric 
characteristics, and presence or absence of follicular cyst 
and corpus luteum. On the other hand, we have recently 
described changes that occur in the expression of 
vimentin and CKs in the ovary of rats with ovarian cysts, 
which are probably due to structural and functional 
modifications that occur during cystogenesis (Salvetti et 
al. 2004b). The present study demonstrates a similar 
pattern of expression of these proteins in cystic follicles 
and confirms the absence of cellular changes in the 
follicular wall of ACTH-treated animals. 
 Numerous lines of evidence suggest that 
important growth-related cellular functions such as cell 
proliferation, expression of differentiated phenotype, 
response to tissue-specific hormones, and tissue 
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morphogenesis are modulated through changes in cellular 
shape (Ben-Ze’Ev and Amsterdam 1987, Marettova and 
Maretta 2002). Since cytoskeletal elements are 
responsible for determining cell morphology and shape, 
this study about cytoskeletal-related protein expression 
was directed towards investigating the possible existence 
of a relation between their immunolocalization and the 
organization of the follicular wall in follicular cysts. The 
occurrence of vimentin-containing granulosa cells has 
been related to mitotic activity, and with follicular atresia 
and dedifferentiation associated with loss of cell-to-cell 
contact (Raymond and Leong 1989, Van den Hurk et al. 
1995). However, if cell proliferation activity in the 
granulosa and theca interna layers is considered to 
decrease in association with the induction of follicular 
cysts, the changes in vimentin expression observed would 
be due to cellular dedifferentiation. The idea that an 
increase in intermediate filaments is a degenerative 
change is also supported by their increase reported in 
many papers (Ghadially et al. 1978, Pieraggi et al. 1984). 
Cell adhesion molecules (cadherins) have been 
identified in the ovaries and linked with cyclic 
remodeling. Although cadherin proteins have been 
identified in cells of developing follicles and corpora 
lutea, their role in ovarian function is unclear (Machell 
and Farookhi 2003). There is evidence that cadherins 
contribute to the structural integrity of follicles and 
corpora lutea. For example, in atretic pig follicles, the 
loss of granulosa cell adhesion and follicle wall integrity 
is associated with a significant decrease in the expression 
of E-cadherin by granulosa cells (Ryan et al. 1996). 
Likewise, a similar decrease in E-cadherin protein has 
been reported in baboon regressing corpora lutea during 
the late luteal phase of the reproductive cycle (Khan-
Dawood et al. 1996). Our results agree with data that 
suggest that disturbances in ovarian cell adhesion in vivo 
are linked with increased atresia, cyst formation, and 
insufficient luteal function (Khan-Dawood et al. 1996, 
Makrigiannakis et al. 1999). In vitro studies indicate that 
cell-cell communication and aggregation are important 
for the differentiation of rat granulosa cells by enhancing 
FSH induction of both aromatase and LH receptors 
(Farookhi and Desjardins 1986). 
 Cystic follicles showed extremely low PCNA 
reaction in the granulosa and theca cell layers, compared 
with healthy follicles, confirming the findings in cows 
with ovarian cystic disease (Isobe and Yoshimura 2000). 
These suggest that the disorder of cell proliferation is also 
associated with the occurrence of follicular cysts in rats. 
Endocrinological aspects 
 Although the exact mechanism involving the 
hypothalamic-pituitary-axis in the PCOS still has to be 
elucidated, it should be noted that closely related 
neuroendocrine mechanisms are involved in the cyclic 
release of ACTH and gonadotropins. In addition, there is 
evidence from both in vitro perfusions and in vivo 
experiments to show that exogenously increased ACTH 
concentrations or stress reduce the amount of LH 
released. In domestic ruminants, treatment with ACTH 
resulted in a reduction of pulsatile LH secretion and in 
the abolition of LH surge without changes in the 
secretion of FSH. In fact, FSH ability to stimulate 
follicular emergence remains despite the development of 
PCOS (Ribadu et al. 2000). Cows with ovarian follicular 
cysts frequently have an abnormal, intermediate 
concentration of progesterone (Hatler et al. 2003). Even 
at these low concentrations of progesterone, the 
preovulatory surge of LH and subsequent ovulation can 
be blocked resulting in the persistence of ovulatory size 
follicles (Duchens et al. 1994). One possible source of 
this progesterone is the adrenal gland, due to treatment of 
cows with ACTH-induced rapid secretion of progesterone 
(Verkerk et al. 1994, Silvia et al. 2005). However, in 
adrenalectomized rats subjected to stress, there was a 
decrease in LH level and an increase in progesterone 
(Galvez et al. 1999). Thus, these hormonal changes could 
represent a reflex action of an extra-adrenal mechanism. 
Our results demonstrate that rats respond to 
ACTH administration with an elevation of corticosterone 
and reduction in LH and FSH (compared with proestrous 
levels), but without changes in the levels of other 
hormones or in ovarian morphology. Stener-Victorin et 
al. (2005) have suggested a metabolic shift toward 
corticosterone synthesis and secretion, and a hyperadrenal 
state in EV-induced PCOS. However, our results clearly 
indicate that the EV-induced PCOS is not associated with 
a hyperadrenal state, because we have found a decrease in 
corticosterone without changes in progesterone. 
Therefore, there was no evidence to show that basal 
adrenal activity differed between constantly light-induced 
PCOS and control rats. 
 In this sense, although some researchers 
postulated that constant light acts on the release of ACTH 
(Singh 1969), we have shown in present report that the 
constant light-induced PCOS takes place without a 
significant increase in the corticosterone levels (an index 
for adrenal activity and ACTH stimulation) (Colak et al. 
2002, Tsilchorozidou et al. 2003, Silvia et al. 2005). This 
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is supported by a recent study that points to the 
participation of the pineal gland, but not the adrenal 
gland, in the pathogenesis of constant light-induced 
PCOS (Prata Lima et al. 2004). These authors showed 
that the ovarian morphology in PCOS induced in rats by 
pinealectomy is similar to that induced by constant light 
exposure. They also demonstrated that in both cases, the 
development of ovarian cysts and anovulation could be 
inhibited by melatonin administration. In this sense, 
melatonin acts on the central nervous system of the 
rodent, with an antigonadotropic action in the anterior 
hypothalamus (Reichlin 1992, Prata Lima et al. 2004). 
 However, it is interesting to mention that 
Paredes et al. (1998) showed that the exposure to stress 
can represent an etiological factor in the genesis of PCOS 
in rats. In this work, the effect on the ovarian function of 
exposure to 3 weeks of stress was not maintained for 
11 weeks. The temporal disruption of ovulation, observed 
by these authors, appears to be the consequence of a 
poorly controlled ovarian function under increased 
sympathetic nerve activity. The increase in 
norepinephrine release after 3 weeks of stress correlates 
with ovarian cyst formation, and the decrease in the 
release found at 11 weeks of stress correlates with the 
recovery of ovarian function to control level (Paredes et 
al. 1998).  
 Among the uncertainties surrounding the 
etiology of the PCOS in women, the role of altered 
cortisol metabolism has become prominent 
(Tsilchorozidou et al. 2003). Enhanced 5α-reductase, 
deregulation of 11β-hydroxysteroid dehydrogenase type 1 
activity, and increased total adrenal steroid production 
rates have been previously described in PCOS and 
implicated as possible pathogenetic mechanisms. 
However, in normal women, circulating adrenal androgen 
levels and their response to ACTH are highly 
individualized and genetically predetermined (Rotter et 
al. 1985, Azziz et al. 1999). Supporting this concept, 
various investigators have observed a significant degree 
of heritability for adrenal androgen levels with an 
increased risk for developing PCOS (Ibanez et al. 1993, 
Thomas et al. 1994, Nafziger et al. 1998, Yildiz et al. 
2004). Recently, Silvia et al. (2005) have reported that 
the naturally occurring cystic condition in cows is not 
associated with abnormalities in adrenal secretion of 
either cortisol or progesterone. These results suggest that 
adrenal dysfunction could act as an inheritable risk factor, 
although this is not the only one in the pathogenesis of 
PCOS (Xita et al. 2002, Silvia et al. 2002, Peter, 2004). 
 In conclusion, treatment with ACTH in rats 
resulted in corticosterone stimulation with LH reduction 
but not changes in ovarian morphology. Although stress 
(or ACTH) stimulation and adrenal hyperactivity may be 
only one pathophysiological mechanism involved in 
follicular cyst pathogenesis in other species, we have not 
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